1492 Capital Management LLC Has $1.75 Million Holdings in DocGo Inc. (NASDAQ:DCGO)

1492 Capital Management LLC decreased its holdings in DocGo Inc. (NASDAQ:DCGO - Free Report) by 21.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 663,499 shares of the company's stock after selling 183,980 shares during the period. 1492 Capital Management LLC owned about 0.65% of DocGo worth $1,752,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of DCGO. Invesco Ltd. grew its position in shares of DocGo by 1.3% during the 4th quarter. Invesco Ltd. now owns 177,953 shares of the company's stock worth $755,000 after purchasing an additional 2,312 shares in the last quarter. Summit Investment Advisors Inc. increased its holdings in shares of DocGo by 38.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock worth $45,000 after purchasing an additional 2,968 shares during the period. MetLife Investment Management LLC increased its holdings in shares of DocGo by 12.1% during the fourth quarter. MetLife Investment Management LLC now owns 60,245 shares of the company's stock worth $255,000 after purchasing an additional 6,517 shares during the period. ProShare Advisors LLC increased its holdings in shares of DocGo by 49.0% during the fourth quarter. ProShare Advisors LLC now owns 28,641 shares of the company's stock worth $121,000 after purchasing an additional 9,425 shares during the period. Finally, Graham Capital Management L.P. increased its holdings in shares of DocGo by 15.6% during the fourth quarter. Graham Capital Management L.P. now owns 71,407 shares of the company's stock worth $303,000 after purchasing an additional 9,624 shares during the period. Institutional investors own 56.44% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. BTIG Research cut shares of DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Canaccord Genuity Group reaffirmed a "hold" rating and set a $1.45 target price (down from $5.00) on shares of DocGo in a report on Monday, May 12th. Finally, Needham & Company LLC lowered their target price on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $3.56.

DocGo Stock Performance

Shares of DocGo stock traded up $0.01 on Friday, reaching $1.46. 256,092 shares of the stock were exchanged, compared to its average volume of 531,024. The firm's 50 day moving average is $1.50 and its 200-day moving average is $2.69. DocGo Inc. has a one year low of $1.23 and a one year high of $5.68. The firm has a market cap of $148.90 million, a PE ratio of -73.00 and a beta of 0.97.

DocGo (NASDAQ:DCGO - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). DocGo had a positive return on equity of 2.52% and a negative net margin of 0.12%. The firm had revenue of $96.03 million for the quarter, compared to the consensus estimate of $104.25 million. On average, equities research analysts expect that DocGo Inc. will post 0.25 EPS for the current fiscal year.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.